Pharmesis International Ltd - ESG Rating & Company Profile powered by AI
Check the end of this page for potential risks for Pharmesis International Ltd based on sector, geography and marketcap. This ESG rating covers seventeen UN SDGs including: 'No Poverty', 'Climate Action' and 'Partnerships for the Goals'. This Sustainability assessment for Pharmesis International Ltd represents its reporting of the UN SDGs.
Pharmesis International Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 0.0, social score of 2.7 and governance score of 8.0.
3.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
| 1132 | Traphaco JSC | 3.7 | Medium |
| 1144 | Pharmesis International Ltd | 3.6 | Medium |
| 1144 | CellSeed Inc | 3.6 | Medium |
| 1144 | Cellectar Biosciences Inc | 3.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Pharmesis International Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pharmesis International Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Pharmesis International Ltd report the average age of the workforce?
Sign up for free to unlockDoes Pharmesis International Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pharmesis International Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pharmesis International Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Pharmesis International Ltd offer flexible work?
Sign up for free to unlockDoes Pharmesis International Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pharmesis International Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pharmesis International Ltd conduct supply chain audits?
Sign up for free to unlockDoes Pharmesis International Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pharmesis International Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pharmesis International Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pharmesis International Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pharmesis International Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pharmesis International Ltd disclose water use targets?
Sign up for free to unlockDoes Pharmesis International Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Pharmesis International Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Pharmesis International Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Pharmesis International Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pharmesis International Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pharmesis International Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Pharmesis International Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pharmesis International Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pharmesis International Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pharmesis International Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pharmesis International Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pharmesis International Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pharmesis International Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Pharmesis International Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pharmesis International Ltd disclose its waste policy?
Sign up for free to unlockDoes Pharmesis International Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Pharmesis International Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pharmesis International Ltd disclose energy use targets?
Sign up for free to unlockDoes Pharmesis International Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pharmesis International Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pharmesis International Ltd
These potential risks are based on the size, segment and geographies of the company.
Pharmesis International Ltd., an investment holding company, researches, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the Kinna brand, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arteriosclerosi, menopausal symptoms, dyspepsia, and adynamia; Lianpushuangqing for acute inflammation; AFenKa to treat migraine, pain, headache, nasosinusitis, cold, muscle pain, menstrual pain, toothache, and arthritis; Xiao Shi Jian Pi to treat flatus, inappetency, dyspepsy, and spleen weakness; and Xiao Luo Tong for the rheumatoid arthritis and other rheumatic diseases treatment. The company also provides TCM formulated products under the Longlife brand name comprising Gulin Gansu for acute and chronic hepatitis treatment; Er Ding granules to treat jaundice, and clear heat and toxics; and Kang Gu Zeng Sheng for boosting the functions of kidney, as well as for increasing blood circulation and alleviating pain. In addition, it offers health supplement products, such as Mei Li Wei Ta to combat aging process and support bone health for women; Hao Xiu Xi to enhance sleep and regulate blood fats; Hao Zhuang Tai to regulate blood fats and fight fatique; and Qianlieman'an for promoting healthy prostate function and colon health, and supporting urinary function, as well as SHULINGHOU for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness. Further, the company engages in the wholesale of chemical drugs, biological raw products, TCM products, antibiotics, and antibiotic agents. Pharmesis International Ltd. was founded in 1996 and is based in Singapore.